Stereotaxis (STXS) Current Deferred Revenue (2010 - 2026)
Stereotaxis (STXS) posted quarterly Current Deferred Revenue of $6.5 million for Q1 2026, down 33.67% year-over-year from $9.9 million in Q1 2025, and up 15.26% quarter-over-quarter from $5.7 million in Q4 2025.
Stereotaxis (STXS) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Current Deferred Revenue for 17 consecutive years, with $6.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 33.67% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $6.5 million (down 33.67% YoY), while the FY2025 annual figure was $5.7 million, down 16.59% from the prior year.
- Current Deferred Revenue rose to $6.5 million in Q1 2026 per STXS's latest filing, from $5.7 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $9.9 million in Q2 2023 and bottomed at $5.0 million in Q2 2024.
- Historically, Current Deferred Revenue has averaged $7.7 million across 5 years, with a median of $7.5 million in 2025.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue surged 43.32% — and 2024, when it plunged 49.81%.
- Stereotaxis' Current Deferred Revenue stood at $9.0 million in 2022, then retreated by 26.0% to $6.7 million in 2023, then rose by 2.21% to $6.8 million in 2024, then fell by 16.59% to $5.7 million in 2025, then advanced by 15.26% to $6.5 million in 2026.
- Business Quant data shows STXS's Current Deferred Revenue at $6.5 million in Q1 2026, $5.7 million in Q4 2025, and $7.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.31 Mn |
| Mar 31, 2026 | 6.54 Mn |
| Dec 31, 2025 | 5.68 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 5.84 Mn |
| Mar 31, 2025 | 9.86 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Sep 30, 2024 | 7.19 Mn |
| Jun 30, 2024 | 4.95 Mn |
| Mar 31, 2024 | 7.52 Mn |
| Dec 31, 2023 | 6.66 Mn |
| Sep 30, 2023 | 8.20 Mn |
| Jun 30, 2023 | 9.86 Mn |
| Mar 31, 2023 | 9.26 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Sep 30, 2022 | 9.46 Mn |
| Jun 30, 2022 | 8.59 Mn |
| Mar 31, 2022 | 8.41 Mn |
| Dec 31, 2021 | 6.28 Mn |
| Sep 30, 2021 | 6.69 Mn |